<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Juni 2024]]></title><description><![CDATA[<p dir="auto">Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030 <a href="https://proinvestor.com/investornyt/1167710/prediction-these-could-be-the-best-performing-pharmaceutical-stocks-through-2030" rel="nofollow ugc">https://proinvestor.com/investornyt/1167710/prediction-these-could-be-the-best-performing-pharmaceutical-stocks-through-2030</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400887/pharma-juni-2024</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 15:21:27 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400887.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 02 Jun 2024 13:07:38 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 25 Jun 2024 04:32:22 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck: FDA accepterer ansøgning for Rexulti som supplerende behandling af PTSD <a href="https://proinvestor.com/investornyt/1177120/lundbeck-fda-accepterer-ansogning-for-rexulti-som-supplerende-behandling-af-ptsd" rel="nofollow ugc">https://proinvestor.com/investornyt/1177120/lundbeck-fda-accepterer-ansogning-for-rexulti-som-supplerende-behandling-af-ptsd</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038098</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038098</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 25 Jun 2024 04:32:22 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 25 Jun 2024 03:04:42 GMT]]></title><description><![CDATA[<p dir="auto">ALK-Abelló får hævet kursmålet hos SEB efter opjustering <a href="https://proinvestor.com/investornyt/1177102/alk-abello-far-haevet-kursmalet-hos-seb-efter-opjustering" rel="nofollow ugc">https://proinvestor.com/investornyt/1177102/alk-abello-far-haevet-kursmalet-hos-seb-efter-opjustering</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038094</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038094</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 25 Jun 2024 03:04:42 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Sat, 22 Jun 2024 03:33:14 GMT]]></title><description><![CDATA[<p dir="auto">ALK opjusterer forventningerne til omsætning og indtjening i 2024 <a href="https://proinvestor.com/boards/121026" rel="nofollow ugc">https://proinvestor.com/boards/121026</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038095</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038095</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 22 Jun 2024 03:33:14 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 11 Jun 2024 02:51:32 GMT]]></title><description><![CDATA[<p dir="auto">Eli Lilly får delvist blåt stempel af muligt Alzheimers-middel <a href="https://proinvestor.com/investornyt/1171327/eli-lilly-far-delvist-blat-stempel-af-muligt-alzheimers-middel" rel="nofollow ugc">https://proinvestor.com/investornyt/1171327/eli-lilly-far-delvist-blat-stempel-af-muligt-alzheimers-middel</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038099</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038099</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 11 Jun 2024 02:51:32 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Sat, 08 Jun 2024 13:56:18 GMT]]></title><description><![CDATA[<p dir="auto">Summary fra ASCO, focus cancer og AstraZeneca..</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038097</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038097</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Sat, 08 Jun 2024 13:56:18 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Sat, 08 Jun 2024 13:55:04 GMT]]></title><description><![CDATA[<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://seekingalpha.com/news/4114301?gt=85a9fd549f963861">
Access to this page has been denied
</a>
</h5>
<p class="card-text line-clamp-3">px-captcha</p>
</div>
<a href="https://seekingalpha.com/news/4114301?gt=85a9fd549f963861" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://seekingalpha.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(seekingalpha.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038091</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038091</guid><dc:creator><![CDATA[Jazzz]]></dc:creator><pubDate>Sat, 08 Jun 2024 13:55:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Sat, 08 Jun 2024 02:50:37 GMT]]></title><description><![CDATA[<h2>Dagens aktie er AddLife</h2>
<p dir="auto">AddLife udvikler og opkøber profitable markedsledende nichevirksomheder inden for Life Science. Tilbyder tilbyder produkter, services og rådgivning af høj kvalitet til både den private og offentlige sektor, primært i Norden og resten af Europa. Læs mere: <a href="https://proinvestor.com/boards/120756/" rel="nofollow ugc">https://proinvestor.com/boards/120756/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038092</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038092</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 08 Jun 2024 02:50:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Wed, 05 Jun 2024 04:28:06 GMT]]></title><description><![CDATA[<p dir="auto">Dagens aktie er Halozyme Therapeutics, Inc..................</p>
<p dir="auto">Halozyme Therapeutics Inc er en biopharma platformsvirksomhed der forsker i, udvikler og kommercialiserer proprietære enzymer. Terapier fokuseret på humane enzymer<br />
Fokuserer på at udvikle sine proprietære produkter inden for terapeutiske områder med udækkede medicinske behov, med fokus på onkologi, og licensere sin teknologi til biofarmaceutiske virksomheder til i fællesskab at udvikle produkter. <a href="https://proinvestor.com/boards/120777" rel="nofollow ugc">https://proinvestor.com/boards/120777</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038090</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038090</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 05 Jun 2024 04:28:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 04 Jun 2024 05:13:37 GMT]]></title><description><![CDATA[<p dir="auto">Er ALK's ambitioner ambitiøse nok spørger Nordnets investeringsøkonom <a href="https://proinvestor.com/investornyt/1168344/er-alks-ambitioner-ambitiose-nok-sporger-nordnets-investeringsokonom" rel="nofollow ugc">https://proinvestor.com/investornyt/1168344/er-alks-ambitioner-ambitiose-nok-sporger-nordnets-investeringsokonom</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038093</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038093</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 04 Jun 2024 05:13:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 04 Jun 2024 03:04:51 GMT]]></title><description><![CDATA[<p dir="auto">ALK dropper samarbejde om adrenalinpenne i USA <a href="https://proinvestor.com/investornyt/1168325/alk-dropper-samarbejde-om-adrenalinpenne-i-usa" rel="nofollow ugc">https://proinvestor.com/investornyt/1168325/alk-dropper-samarbejde-om-adrenalinpenne-i-usa</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038088</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038088</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 04 Jun 2024 03:04:51 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Tue, 04 Jun 2024 03:03:41 GMT]]></title><description><![CDATA[<p dir="auto">ALK vil vokse med mindst 10 pct. om året frem til 2028 <a href="https://proinvestor.com/investornyt/1168326/alk-vil-vokse-med-mindst-10-pct-om-aret-frem-til-2028" rel="nofollow ugc">https://proinvestor.com/investornyt/1168326/alk-vil-vokse-med-mindst-10-pct-om-aret-frem-til-2028</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038087</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038087</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 04 Jun 2024 03:03:41 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Mon, 03 Jun 2024 07:59:53 GMT]]></title><description><![CDATA[<p dir="auto">ALK præsenterer lovende resultater med allergivacciner i børn <a href="https://proinvestor.com/investornyt/1167824/alk-praesenterer-lovende-resultater-med-allergivacciner-i-born" rel="nofollow ugc">https://proinvestor.com/investornyt/1167824/alk-praesenterer-lovende-resultater-med-allergivacciner-i-born</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038096</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038096</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 03 Jun 2024 07:59:53 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Mon, 03 Jun 2024 07:55:42 GMT]]></title><description><![CDATA[<p dir="auto">ALK's kapitalmarkedsdag nærmer sig: DNB ser uændret ambition om tocifret vækst <a href="https://proinvestor.com/investornyt/1167816/alks-kapitalmarkedsdag-naermer-sig-dnb-ser-uaendret-ambition-om-tocifret-vaekst" rel="nofollow ugc">https://proinvestor.com/investornyt/1167816/alks-kapitalmarkedsdag-naermer-sig-dnb-ser-uaendret-ambition-om-tocifret-vaekst</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038086</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038086</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 03 Jun 2024 07:55:42 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Mon, 03 Jun 2024 06:19:55 GMT]]></title><description><![CDATA[<p dir="auto">Den britiske medicinalkæmpe GlaxoSmithKline (GSK) styrtdykker mandag morgen med knap 10 pct. på børsen i London, efter at en amerikansk domstol har afgjort, at selskabet skal for retten i et hav af søgsmål. <a href="https://proinvestor.com/investornyt/1167811/britisk-medicinalkaempe-sendt-til-taelling-amerikansk-domstol-abner-for-hav-af-sogsmal" rel="nofollow ugc">https://proinvestor.com/investornyt/1167811/britisk-medicinalkaempe-sendt-til-taelling-amerikansk-domstol-abner-for-hav-af-sogsmal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038089</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038089</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 03 Jun 2024 06:19:55 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Juni 2024 on Mon, 03 Jun 2024 03:37:50 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038085</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038085</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 03 Jun 2024 03:37:50 GMT</pubDate></item></channel></rss>